Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $753.32 billion, total revenue of $168.76 billion and a weighted average PE ratio of 43.06.
Market Cap
753.32B
Revenue
168.76B
Profits
17.49B
PE Ratio
43.06
Profit Margin
10.37%
Dividend Yield
0.22%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 192.35B | -1.12% | 1,857,761 | 45.20B |
| 2 | DHR | Danaher Corporation | 137.04B | -2.18% | 4,663,822 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.57B | 1.29% | 631,627 | 4.45B |
| 4 | NTRA | Natera, Inc. | 40.64B | 1.60% | 1,358,431 | 2.50B |
| 5 | WAT | Waters Corporation | 37.20B | -0.11% | 771,724 | 3.77B |
| 6 | A | Agilent Technologies, Inc. | 36.89B | -0.07% | 1,999,968 | 7.23B |
| 7 | IQV | IQVIA Holdings Inc. | 34.38B | -0.52% | 896,332 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 29.40B | 2.99% | 2,103,315 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 26.18B | -0.98% | 165,124 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 23.63B | -1.05% | 745,936 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 23.32B | -0.90% | 491,376 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 22.39B | 0.50% | 2,174,579 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.14B | 1.34% | 234,157 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 13.09B | -1.23% | 777,141 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 12.60B | -0.71% | 1,006,155 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 11.15B | 0.32% | 631,920 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.10B | -2.37% | 2,235,210 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 6.22B | 0.70% | 1,446,531 | 409.48M |
| 19 | BLLN | BillionToOne, Inc. | 5.68B | 2.53% | 780,666 | 354.54M |
| 20 | RDNT | RadNet, Inc. | 5.42B | 0.25% | 1,105,221 | 2.14B |
| 21 | SHC | Sotera Health Company | 5.09B | -0.39% | 1,989,210 | 1.19B |
| 22 | VCYT | Veracyte, Inc. | 4.63B | 1.60% | 894,567 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.44B | 1.46% | 2,525,110 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.96B | -0.23% | 240,691 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 2.05B | 2.04% | 690,232 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.97B | - | 3,165,588 | 745.97M |
| 27 | PSNL | Personalis, Inc. | 1.50B | 5.29% | 4,578,100 | 64.52M |
| 28 | CDNA | CareDx, Inc. | 1.50B | -0.45% | 723,602 | 412.82M |
| 29 | OPK | OPKO Health, Inc. | 1.13B | -1.32% | 1,956,266 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 734.29M | 0.37% | 187,687 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 607.49M | 2.59% | 190,158 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 569.52M | 0.67% | 1,063,742 | 829.00M |
| 33 | BDSX | Biodesix, Inc. | 226.27M | -0.64% | 39,984 | 96.10M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 182.12M | -1.74% | 45,197 | 1.95M |
| 35 | BNR | Burning Rock Biotech Limited | 108.94M | 5.19% | 9,317 | 74.58M |
| 36 | XGN | Exagen Inc. | 106.30M | -3.08% | 145,703 | 68.38M |
| 37 | PRPO | Precipio, Inc. | 45.15M | - | 62,608 | 25.83M |
| 38 | MDXH | MDxHealth SA | 24.82M | 1.41% | 318,716 | 110.97M |
| 39 | QUCY | Quantum Cyber N.V. | 21.11M | -0.69% | 1,078,107 | 537.08K |
| 40 | XWEL | XWELL, Inc. | 9.20M | 1.87% | 24,523 | 28.83M |
| 41 | MBAI | Check-Cap Ltd. | 8.45M | 1.75% | 18,764 | - |
| 42 | ADVB | Advanced Biomed Inc. | 8.38M | 1.70% | 3,699 | - |
| 43 | NDRA | ENDRA Life Sciences Inc. | 6.08M | 1.48% | 26,475 | - |
| 44 | ISPC | iSpecimen Inc. | 3.69M | -2.65% | 21,332 | 1.03M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 3.66M | -2.63% | 225,932 | 5.66M |